All ProductsDisplaying Products by Catalog Number (6600 - 6699)
0100020003000400050006000700080009001000110012001300140015001600170018001900200021002200230024002500260027002800290030003100320033003400350036003700380039004000410042004300440045004600470048004900500051005200530054005500560057005800590060006100620063006400650066006700680069007000710072007300740075007600770078007900
| Cat. No. | Product Name / Activity |
|---|---|
| 6602 | 1M7 |
| Reagent for RNA SHAPE-MaP chemistry | |
| 6603 | RIPK2 inhibitor 1 New |
| Potent RIPK2 inhibitor | |
| 6604 | VER 246608 |
| Potent and selective pyruvate dehydrogenase kinase (PDK) 1/2/3/4 inhibitor | |
| 6605 | dTAG-13 |
| Degrades mutant FKBP12F36V fusion proteins; useful alternative to genetic methods for target validation | |
| 6606 | dBRD9 |
| Potent and selective BRD9 Degrader (PROTAC®) | |
| 6607 | dTRIM 24 |
| TRIM24 Degrader (PROTAC®) | |
| 6614 | Jedi2 |
| Piezo1 channel activator | |
| 6615 | KCC 07 |
| MBD2 (Methyl-CpG-binding domain protein 2) inhibitor | |
| 6617 | LYN 1604 dihydrochloride New |
| Potent UNC-51-like kinase 1 (ULK1) agonist | |
| 6618 | MB 05032 |
| Potent FBPase inhibitor; promotes HSC expansion | |
| 6626 | AP C5 |
| Potent and selective PKG2 inhibitor | |
| 6627 | Thalidomide 4'-ether-alkylC6-amine |
| Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
| 6628 | TC E3 5032 |
| Precursor to Pomalidomide-based PROTACs | |
| 6632 | ERGi-USU |
| Rio2 kinase (RIOK2) inhibitor; inhibits ERG protein | |
| 6634 | Surfen |
| Heparin sulfate antagonist | |
| 6637 | Pomalidomide 4'-PEG2-amine |
| Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
| 6638 | GSK 626616 |
| Potent and selective DYRK inhibitor; orally bioavailable. | |
| 6641 | Roflumilast |
| Potent and selective PDE4 inhibitor | |
| 6642 | QWF |
| MRGPRX2 antagonist; also NK1 receptor antagonist | |
| 6644 | KuWal151 |
| Potent and selective CLK inhibitor | |
| 6645 | DJ-V 159 |
| GPRC6A agonist | |
| 6646 | CDDO-Me |
| Nrf2 pathway activator; also NF-κB pathway inhibitor; inhibits IKKβ | |
| 6647 | HADA |
| Blue fluorescent D-amino acid for labeling peptidoglycans in live bacteria | |
| 6648 | NADA-green |
| Fluorescent D-amino acid for labeling peptidoglycans in live bacteria | |
| 6649 | RADA |
| Orange-red TAMRA-based fluorescent D-amino acid for labeling peptidoglycans in live bacteria | |
| 6650 | YADA |
| Green-yellow lucifer yellow-based fluorescent D-amino acid for labeling peptidoglycans in live bacteria | |
| 6652 | NGI 1 |
| Oligosaccharyltransferase (OST) inhibitor; anti-flaviviral | |
| 6653 | FM19G11 |
| HIF α-subunit inhibitor | |
| 6654 | VAS 2870 |
| NADPH oxidase (Nox) inhibitor | |
| 6655 | Amifostine |
| Cytoprotectant | |
| 6657 | PA 8 |
| PAC1 receptor antagonist | |
| 6658 | Telaprevir |
| Hepatitis C virus (HCV) protease NS3/4A inhibitor | |
| 6660 | Crotonic Acid |
| Enhances reprogramming to pluripotency; facilitates telomere maintenance and increases telomere length | |
| 6662 | 4-Octyl itaconate |
| Nrf2 activator; cell permeable | |
| 6663 | Silodosin |
| Selective α1A antagonist | |
| 6664 | Kinesore |
| Kinesin-1 modulator; cell permeable | |
| 6665 | BI 9321 |
| Nuclear receptor-binding SET domain (NSD) 3 antagonist; selectively binds PWWP1 domain | |
| 6666 | T3 |
| Thyroid hormone; also promotes differentiation of oligodendroglial precursor cells | |
| 6668 | ML 184 |
| Selective GPR55 agonist; also promotes NSC proliferation and differentiation | |
| 6669 | Gly MCA |
| FXR antagonist; selectively active in intestines; orally bioavailable | |
| 6670 | TP 238 |
| CECR2 and BPTF/FALZ inhibitor | |
| 6675 | H 151 |
| STING antagonist | |
| 6676 | IC 261 |
| CK1 inhibitor; displays selectivity for CK1δ and CK1ε | |
| 6677 | CMA |
| Murine-selective STING agonist | |
| 6679 | VH 032 amide-PEG3-acid |
| VHL ligand with PEG linker and terminal acid for onward chemistry | |
| 6680 | VH 032 amide-alkylC4-acid |
| VHL ligand with alkyl linker and terminal acid for onward chemistry | |
| 6681 | Pomalidomide 4'-PEG3-acid |
| Cereblon ligand with PEG linker and terminal acid for onward chemistry | |
| 6682 | Pomalidomide 4'-alkylC5-acid |
| Cereblon ligand with alkyl linker and terminal acid for onward chemistry | |
| 6683 | VH 032, propargyl |
| Alkyne-functionalized VH 032; 'click' VHL ligand for PROTACs | |
| 6684 | VH 032 amide-PEG2-alkyne |
| VHL ligand with PEG linker and terminal alkyne for onward chemistry | |
| 6685 | Thalidomide, propargyl |
| Alkyne-functionalized Thalidomide; 'click' cereblon ligand for PROTACs | |
| 6686 | Thalidomide 4'-ether-PEG2-alkyne |
| Cereblon ligand with PEG linker and terminal alkyne for onward chemistry | |
| 6687 | 1R,3R-RSL3 |
| Negative control for 1S,3R-RSL3 (Cat. No. 6118) | |
| 6689 | GI 530159 |
| K2P2.1 (TREK-1) and K2P10.1 (TREK-2) channel activator | |
| 6690 | Ceralifimod |
| Highly potent and selective S1P1 and S1P5 agonist | |
| 6691 | LP 922056 |
| Notum inhibitor; activates Wnt signaling | |
| 6692 | WM 1119 |
| High affinity KAT6A (MOZ) competitive inhibitor | |
| 6693 | WM 8014 |
| Potent and selective KAT6A and KAT6B inhibitor | |
| 6695 | CHIR 98014 |
| Highly potent and selective GSK-3 inhibitor | |
| 6699 | [D-Ala2]-GIP (human) |
| Highly potent GIP agonist |